Convergence: FDA officials offer updates on START and STAR pilots
US Food and Drug Administration (FDA) officials shared an update on the status and progress of two pilot programs that aim to promote the development of innovative medicines at RAPS Convergence 2024. One addresses the development of treatments for rare diseases, while the other is intended to speed the development of therapies that address an unmet medical need.
Published on the 24th of september 2024. Please find further details here.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (19 novembre 2024). Convergence: FDA officials offer updates on START and STAR pilots. ELSIBI. Consulté le 16 janvier 2025 à l’adresse https://doi.org/10.58079/12prv
